Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation

Genes and Development

Volumn 12, Issue 21, 1998, Pages 3357-3368

  McInerney, Eileen M ^a   Rose, David W ^a   Flynn, Sarah E ^a   Westin, Stefan ^b   Mullen, Tina Marie ^a   Krones, Anna ^a   Inostroza, Juan ^a   Torchia, Joseph ^a,e   Nolte, Robert T ^d   Assa Munt, Nuria ^c   Milburn, Michael V ^d   Glass, Christopher K ^a,b   Rosenfeld, Michael G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BURNHAM INSTITUTE   (United States)

^d Division of Chemistry   (United States)

^e LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

CBP p300; LXXLL motifs; NCoA SRC factors; Nuclear receptors

Indexed keywords

CELL NUCLEUS RECEPTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SPECIFICITY; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; GENE ACTIVATION; HYDROPHOBICITY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0032213938     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.21.3357     Document Type: Article

References (54)

1. Alland, L., R. Muhle, H. Hou, J. Potes, L. Chin, N. Schreiber-Agus, and R.A. DePinho. 1997. Role for NCoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387: 49-55.
2. Anzick, S.L., J. Kononen, R.L. Walker, D.O. Azorsa, M.M. Tanner, X.Y. Guan, G. Sauter, O.P Kallioniemi, J.M. Trent, and P.S. Meltzer. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965-968.
3. Barettino, D., M.M. Vivanco Ruiz, and H.G. Stunnenberg. 1994. Characterization of the ligand-dependent transactivation by steroid hormone receptors. EMBO J. 13: 3039-3049.
4. Beekman, J.M., G.F. Allan, S.Y. Tsai, and B.W. O'Malley. 1993. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol. Endocrinol. 7: 1266-1274.
5. Bourguet, W., M. Ruff, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375: 377-382.
6. Brzozowski, A.M., A.C.W. Pike, Z. Dauter, R.E. Hubbard, T. Bonn, O. Engstrom, L. Ohman, G.L. Greene, J.-A. Gustafsson, and M. Carlquist. 1997. Molecular basis of agonism and antagonism of oestrogen receptor. Nature 389: 753-758.
7. Brunger, A. 1992. X-PLOR Version 3.0: A system for crystallography and NMR. Yale University Press, New Haven, CT.
8. Cavailles, V., S. Dauvois, P.S. Danielain, and M.G. Parker. 1994. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. 91: 10009-10013.
9. Chakravarti, D., V.J. LaMorte, M.C. Nelson, T. Nakajima, I.G. Schulman, H. Juguilon, M. Montminy, and R.M. Evans. 1996. Role of CBP/p300 in nuclear receptor signalling. Nature 383: 99-103.
10. Chen, H., R.J. Lin, R.L. Schiltz, D. Chkravarti, A. Nash, L. Nagy, M.L. Privalsky, Y. Nakatani, and R.M. Evans. 1997. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with p/CAF and CBP/p300. Cell 90: 569-580.
11. Collaborative Computational Project Number 4. 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. Sect. D Biol. Crystallogr. 50: 760-776.
12. Danielian, P.S., R. White, J.A. Lees, and M.G. Parker. 1992. Identification of a conserved region required for hormone-dependent transcriptional activation by steroid hormone receptors. EMBO J. 11: 1025-1033.
13. Durand, B., M. Saunders, C. Gaudon, B. Roy, R. Losson, and P. Chambon. 1994. Activation function-2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: Presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13: 5370-5382.
14. Fondell, J.D., H. Ge, and R.G. Roeder. 1996. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl. Acad. Sci. 93: 8329-8333.
15. Fritsch, M., C.M. Leary, J.D. Furlow, H. Ahrens, T.J. Schuh, G.C. Mueller, and J. Gorski. 1992. A ligand-induced conformational change in the estrogen receptor is localized in the steroid binding domain. Biochemistry 31: 5303-5311.
16. Halachmi, S., E. Marden, G. Martin, H. MacKay, C. Abbondanza, and M. Brown. 1994. Estrogen receptor-associated proteins: Possible mediators of hormone-induced transcription. Science 264: 1455-1458.
17. Hanstein, B., R. Eckner, J. DiRenzo, S. Halachmi, H. Liu, B. Searcy, R. Kurokawa, and M. Brown. 1996. p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. 93: 11540-11545.
18. Heery, D.M., E. Kalkhoven, S. Hoare, and M.G. Parker. 1997. A signature motif in transcriptional coactivators mediates binding to nuclear receptors. Nature 387: 733-736.
19. Heinzel, T., R.M. Lavinsky, T.M. Mullen, M. Soderstrom, C.D. Laherty, J. Torchia, W. M. Yang, G. Brard, S.D. Ngo, J.R. Davie, E. Seto, R.N. Eisenman, D.W. Rose, C.K. Glass, and M.G. Rosenfeld. 1997. A complex containing NCoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387: 43-48.
20. Hong, H., K. Kohli, A. Trivedi, D.L. Johnson, and M.R. Stallcup. 1996. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. 93: 4948-4952.
21. Horlein, A.J., A.M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C.K. Glass, and M.G. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397-404.
22. Jones, T.A., M. Bergdoll, M. Kjeldgaard, and S. Ealick. 1989. In Crystallographic computing and modeling methods in molecular design (ed. C. Bugg). Springer, New York, NY.
23. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.C. Lin, R.A. Heyman, D.W. Rose, C.K. Glass, and M.G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 7: 1266-1274.
24. Katzenellenbogen, B.S. 1996. Estrogen receptors: Bioactivities and interactions with cell signaling pathways. Biol. Reprod. 54: 287-293.
25. Koch, A., D. Anderson, M.F. Moran, C. Ellis, and T. Pawson. 1991. SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science 252: 668-674.
26. Korzus, E, J. Torchia, D.W. Rose, L. Xu, R. Kurokawa, E.M. Mclnerney, T.M. Mullen, C.K. Glass, and M.G. Rosenfeld. 1998. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279: 703-707.
27. Kraus, W.L. and J.T. Kadonaga. 1998. p300 and estrogen receptors cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes & Dev. 12: 331-342.
28. Kurokawa, R., M. Soderstrom, A. Horlein, S. Halamachi, M. Brown, M.G. Rosenfeld, and C.K. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a corepressor. Nature 377: 451-454.
29. LeDouarin, B., A.L. Nielsen, J.M. Garnier, H. Ichinose, F. Jeanmougin, R. Losson, and P. Chambon. 1996. A possible involvement of TIF1α and TIF1β in the epigenetic control of transcription by nuclear receptors. EMBO J. 15: 6701-6715.
30. Lee, J.W., H.S. Choi, J. Gyuris, R. Brent, and D.D. Moore. 1995. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with thyroid hormone receptor. Mol. Endocrinol. 9: 243-254.
31. Li, H., P.J. Gomes, and J.D. Chen. 1997. RAC3, a steroid/ nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc. Natl. Acad. Sci. 94: 8479-8484.
32. Mangelsdorf, D.J., C. Thummel, M. Beato, P, Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R.M. Evans. 1995. The nuclear receptor superfamily: The second decade. Cell 83: 835-839.
33. Nagy, L., H.Y. Kao, D. Chakravarti, R.J. Lin, C.A. Hassig, D.E. Ayer, S.L. Schreiber, and R.M. Evans. 1997 Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89: 373-380.
34. Nolte, R.T., B. Wisely, S. Westin, J.E. Cobb, M.H. Lambert, R. Kurokawa, M.G. Rosenfeld, T.M. Willson, C.K. Glass, and M.V. Milburn. 1998 Ligand binding and coactivator assembly of the peroxisome proliferator-activated receptor γ. Nature 395: 137-144.
35. Ogryzko, V.V., R.L. Schiltz, V. Russanova, B.H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959.
36. Ogryzko, V.V., T. Kotani, X. Zhang, R.L. Schlitz, T. Howard, X.J. Yang, B.H. Howard, J. Qin, and Y. Nakatani. 1998. Histone-like TAFs within the pCAF histone deacetylase complex. Cell 94: 35-44.
37. Oñate, S.A., S.Y. Tsai, M.J. Tsai, and B.W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354-1357.
38. Pawson, T. and J.D. Scott. 1997. Signaling through scaffold, anchoring, and adaptor proteins. Science 278: 2075-2081.
39. Rachez, C., Z. Suldan, J. Ward, C.P.B. Chang, D. Burakov, H. Erdjument-Bromage, P, Tempst, and L.P. Freedman. 1998. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes & Dev. 12: 1787-1800.
40. Radhakrishnan, I., G.C. Perez-Alvarado, D. Parker, H. J. Dyson, M.R. Montminy, and P.E. Wright. 1997. Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: A model for activator:coactivator interactions. Cell 91: 741-753.
41. Renaud, J.P., N. Rochel, M. Ruff, V. Vivat, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the RAR-γ ligand binding domain bound to all-trans retinoic acid. Nature 378: 681-689.
42. Spencer, T.E., G. Jenster, M.M. Burcin, C.D Allis, J. Zhou, C.A. Mizzen, N.J. McKenna, S.A. Onate, S.Y. Tsai, M.J. Tsai, and B.W. O'Malley. 1997 Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389: 194-198.
43. Tone, Y., T.N. Collinwood, M. Adams, and V.K. Chattergee. 1994. Functional analysis of a transactivation domain in the thyroid hormone receptor. J. Biol. Chem. 269: 31157-31161.
44. Torchia, J., D.W. Rose, J. Inostroza, Y. Kamei, S. Westin, C.K. Glass, and M.G. Rosenfeld. 1997. The transcriptional coactivator p/CIP binds CBP and mediates nuclear receptor function. Nature 387: 677-684.
45. Torchia, J., C.K. Glass, and M.G. Rosenfeld. 1998. Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell. Biol. 10: 373-383.
46. Tzukerman, M.T., A. Esty, D. Santiso-Mere, P. Danielian, M.G. Parker, R.B. Stein, J.W. Pike, and D.P. McDonnell. 1994. Human estrogen receptor transactivation capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8: 21-30.
47. van der Geer, P. and T. Pawson. 1995. The PTB domain: A new protein module implicated in signal transduction (phosphotyrosine-binding). Trends Biochem. Sci. 20.
48. Voegel, J.J., M.J.S. Heine, C. Zechel, P. Chambon, and H. Gronemeyer. 1996. TIF2, a 160kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15: 3667-3675.
49. Wagner, R.L., J. W. Apriletti, M.E. McGrath, B.L. West, J.D. Baxter, and R.J. Fletterick. 1995. A structural role for hormone in the thyroid hormone receptor. Nature 378: 690-697.
50. Westin, S., R. Kurokawa, R.T. Nolte, B. Wisely, E.M. McInerney, D.W. Rose, M.V. Milburn, M.G. Rosenfeld, and C.K. Glass. 1998. Allosteric interactions governing the assembly, structure and function of nuclear receptor heterodimer-co-activator complexes. Nature 395: 199-203.
51. Wong, J., Y.B. Shi, and A.P. Wolffe. 1997. Determinants of chromatin disruption and transcriptional regulation instigated by thyroid hormone receptor: Hormone-regulated chromatin disruption is not sufficient for transcriptional activation. EMBO J. 11: 3158-3171.
52. Xu, L., R.M. Lavinsky, J.S. Dasen, S.E. Flynn, E.M. McInerney, T.-M. Mullen, T. Heinzel, D. Szeto, E. Korzus, R. Kurokawa, A.K. Aggarwal, D.W. Rose, C.K. Glass, and M.G. Rosenfeld. 1998. Distinct histone acetyltransferases and CBP domains are required for activation of Pit-1 by different signalling pathways. Nature 395: 301-306.
53. Yao, T.-P., G. Ku, N. Zhou, R. Scully, and D.M. Livingston. 1996. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sci. 93: 10626-10631.
54. Yao, T.P., S.P. Oh, M. Fuchs, N.-D. Zhou, L.-E. Ch'ng, D. Newsome, R.T. Bronson, E. Li, D.M. Livingston, and R. Eckner. 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93: 361-472.